Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG.

In a late-stage clinical trial of 517 patients, which compared Aveo's drug against Nexavar, a treatment comarketed by Onyx Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc., tivozanib met its goal of slowing progression of the disease.

The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG.

Rivaroxaban was discovered by Bayer HealthCare, and is being jointly developed with Janssen Research & Development, LLC.

View the Par complaint here. Bayer Pharma AG et al. v. Par Pharmaceutical Inc. et al. 1:13-cv-00845; filed May 14, 2013 in the District Court of Delaware.

Prior to joining A.P. Pharma as Senior Vice President and Chief Commercial Officer Mr. Rosen served as global head of oncology at Bayer HealthCare where he was responsible for the development of the global oncology business unit for regions that ...

About Bayer HealthCare Pharmaceuticals Inc. Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG.

The HealthCare segment of Bayer (BAYRY - Analyst Report) recently announced positive results from an interim analysis of the phase III PATENT-2 trial on its pipeline candidate riociguat.

Other vendors mentioned in the report are Affymetrix Inc., Agilent Technologies Inc., Alere Inc., AmniSure International LLC, Anadys Pharmaceuticals Inc., Bayer HealthCare AG, Biocartis SA, bioMerieux SA, Bio-Rad Laboratories Inc., Biotest AG, Carmel ...